Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong
· Delayed Price · Currency is HKD 24.00
-0.60 (-2.44%)
Apr 29, 2026, 4:08 PM HKT
Xuanzhu Biopharmaceutical Revenue
In the year 2025, Xuanzhu Biopharmaceutical had annual revenue of 51.77M CNY with 72.03% growth. Xuanzhu Biopharmaceutical had revenue of 33.88M in the half year ending December 31, 2025.
Revenue
51.77M CNY
Revenue Growth
+72.03%
P/S Ratio
215.77
Revenue / Employee
262.80K CNY
Employees
197
Market Cap
12.43B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CanSino Biologics | 1.19B |
| Sihuan Pharmaceutical Holdings Group | 2.91B |
| Consun Pharmaceutical Group | 3.80B |
| Ab&B Bio-Tech CO., LTD. JS | 354.77M |
| Luye Pharma Group | 7.02B |
| Shandong Xinhua Pharmaceutical Company | 9.74B |
| The United Laboratories International Holdings | 14.70B |
| China Traditional Chinese Medicine Holdings Co. | 16.41B |